Stocktoria
Inogen Inc INGN
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2014-02-14
Inogen Inc statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 44.2% | 46.1% | 40.1% | 40.7% | 49.3% |
| Operating margin | -8.7% | -12.7% | -34.7% | -22.6% | 2.6% |
| Net margin | -6.5% | -10.7% | -32.5% | -22.2% | -1.8% |
| FCF margin | -3.9% | 0.8% | -2.7% | -10.8% | 5.1% |
| Return on assets | -7.6% | -12.1% | -31.4% | -20.7% | -1.3% |
| Return on equity | -11.8% | -20.6% | -50.0% | -28.2% | -1.7% |
| Current ratio | 3.12 | 2.42 | 2.86 | 4.66 | 5.35 |
| Revenue growth | 3.9% | 6.4% | -16.3% | 5.4% | 16.1% |
Source: SEC EDGAR filings · CIK 0001294133 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.